279 related articles for article (PubMed ID: 19369694)
41. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
[TBL] [Abstract][Full Text] [Related]
42. Role of sphingosine 1-phosphate in skeletal muscle cell biology.
Bruni P; Donati C
Handb Exp Pharmacol; 2013; (216):457-67. PubMed ID: 23563671
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression.
Gorshkova I; Zhou T; Mathew B; Jacobson JR; Takekoshi D; Bhattacharya P; Smith B; Aydogan B; Weichselbaum RR; Natarajan V; Garcia JG; Berdyshev EV
J Lipid Res; 2012 Aug; 53(8):1553-68. PubMed ID: 22615416
[TBL] [Abstract][Full Text] [Related]
44. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase.
Facchinetti MM; Beuret C; Marquez MG; Sterin-Speziale N
Biol Neonate; 2003; 84(3):243-51. PubMed ID: 14504448
[TBL] [Abstract][Full Text] [Related]
45. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts.
Meacci E; Cencetti F; Donati C; Nuti F; Becciolini L; Bruni P
Biochem J; 2004 Aug; 381(Pt 3):655-63. PubMed ID: 15109308
[TBL] [Abstract][Full Text] [Related]
47. Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.
Russo SB; Tidhar R; Futerman AH; Cowart LA
J Biol Chem; 2013 May; 288(19):13397-409. PubMed ID: 23530041
[TBL] [Abstract][Full Text] [Related]
48. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
49. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.
Fayyaz S; Henkel J; Japtok L; Krämer S; Damm G; Seehofer D; Püschel GP; Kleuser B
Diabetologia; 2014 Feb; 57(2):373-82. PubMed ID: 24292566
[TBL] [Abstract][Full Text] [Related]
50. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine Kinases: Emerging Structure-Function Insights.
Adams DR; Pyne S; Pyne NJ
Trends Biochem Sci; 2016 May; 41(5):395-409. PubMed ID: 27021309
[TBL] [Abstract][Full Text] [Related]
52. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator.
Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A
FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724
[TBL] [Abstract][Full Text] [Related]
53. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.
Baran Y; Salas A; Senkal CE; Gunduz U; Bielawski J; Obeid LM; Ogretmen B
J Biol Chem; 2007 Apr; 282(15):10922-34. PubMed ID: 17303574
[TBL] [Abstract][Full Text] [Related]
54. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
55. Sphingosine kinase 1 is up-regulated in colon carcinogenesis.
Kawamori T; Osta W; Johnson KR; Pettus BJ; Bielawski J; Tanaka T; Wargovich MJ; Reddy BS; Hannun YA; Obeid LM; Zhou D
FASEB J; 2006 Feb; 20(2):386-8. PubMed ID: 16319132
[TBL] [Abstract][Full Text] [Related]
56. A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells.
Brown RDR; Veerman BEP; Oh J; Tate RJ; Torta F; Cunningham MR; Adams DR; Pyne S; Pyne NJ
J Biol Chem; 2021; 296():100674. PubMed ID: 33865856
[TBL] [Abstract][Full Text] [Related]
57. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
58. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
59. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
Maceyka M; Milstien S; Spiegel S
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
[TBL] [Abstract][Full Text] [Related]
60. New aspects of sphingosine 1-phosphate signaling in mammalian cells.
Pyne NJ; Long JS; Lee SC; Loveridge C; Gillies L; Pyne S
Adv Enzyme Regul; 2009; 49(1):214-21. PubMed ID: 19534035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
